The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The role of STATs in transcriptional control and their impact on cellular function
Abstract
The STAT proteins (Signal Transducers and Activators of Transcription), were identified in the last decade as transcription factors which were critical in mediating virtually all cytokine driven signaling. These proteins are latent in the cytoplasm and become activated through tyrosine phosphorylation which typically occurs through cytokine receptor associated kinases (JAKs) or growth factor receptor tyrosine kinases. Recently a number of non-receptor tyrosine kinases (for example src and abl) have been found to cause STAT phosphorylation. Phosphorylated STATs form homo- or hetero-dimers, enter the nucleus and working coordinately with other transcriptional co-activators or transcription factors lead to increased transcriptional initiation. In normal cells and in animals, ligand dependent activation of the STATs is a transient process, lasting for several minutes to several hours. In contrast, in many cancerous cell lines and tumors, where growth factor dysregulation is frequently at the heart of cellular transformation, the STAT proteins (in particular Stats 1, 3 and 5) are persistently tyrosine phosphorylated or activated. The importance of STAT activation to growth control in experiments using anti-sense molecules or dominant negative STAT protein encoding constructs performed in cell lines or studies in animals lacking specific STATs strongly indicate that STATs play an important role in controlling cell cycle progression and apoptosis. Stat1 plays an important role in growth arrest, in promoting apoptosis and is implicated as a tumor suppressor; while Stats 3 and 5 are involved in promoting cell cycle progression and cellular transformation and preventing apoptosis. Many questions remain including: (1) a better understanding of how the STAT proteins through association with other factors increase transcription initiation; (2) a more complete definition of the sets of genes which are activated by different STATs and (3) how these sets of activated genes differ as a function of cell type. Finally, in the context of many cancers, where STATs are frequently persistently activated, an understanding of the mechanisms leading to their constitutive activation and defining the potential importance of persistent STAT activation in human tumorigenesis remains. Oncogene (2000).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 is also a key factor in inflammation, autoimmunity and cancer, with its effect mainly exerted through the IL-6–signal transducer and activator of transcription 3 (STAT3) pathway (18–26, 61–65).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [61]
In the citing paper
“HCV core protein interacts with the signal transducer and activator of transcription 3 (STAT3) protein36, a transcription factor involved in mediating cytokine signalling37.”
From Inflammation and cancer (2002) · cites this paper as [37]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,539
A Matter of Life and Cell Death
Evan, G. I., & Littlewood, T. D. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,528
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,000
Nuclear retention of STAT3 through the coiled-coil domain regulates its activity
Sato, N., Tsuruma, R., Imoto, S., Sekine, Y., Muromoto, R., Sugiyama, K., & Matsuda, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.145 · Cited by 28
Cross-talk between endocrine-disrupting chemicals and cytokine signaling through estrogen receptors
Sekine, Y., Yamamoto, T., Yumioka, T., Imoto, S., Kojima, H., & Matsuda, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.109 · Cited by 26
Tracey, L., Spiteri, I., Ortiz-Romero, P. L., Lawler, M., Piris, M. A., & Villuendas, R. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/107999004322917034 · Cited by 26
Rosen, D. B., Putta, S., Covey, T. M., Huang, Y.-W., Nolan, G. P., Cesano, A., Minden, M. D., & Fantl, W. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012405 · Cited by 25
Sarkar, R., Mitra, D., & Chakrabarti, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059073 · Cited by 28
Ali, S. A., Kaur, G., Kaushik, J. K., Malakar, D., Mohanty, A. K., & Kumar, S. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.07.014 · Cited by 25
Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma
Wang, Z., Yan, M., Li, J., Long, J., Li, Y., & Zhang, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.11.016 · Cited by 25
STAT3 as a therapeutic target in the metformin-related treatment.
Zhang, W.-R., Li, D., Li, B., Chu, X., & Kong, B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109770 · Cited by 25
Stat5 as a diagnostic marker for leukemia
Lewis, R. S., & Ward, A. C. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.1.73 · Cited by 25
Halachmi, S., AITKEN, K. J., Szybowska, M., Sabha, N., Dessouki, S., Lorenzo, A. J., Tse, D., & Bägli, D. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0204-6 · Cited by 25
IL-18 induces profibrotic renal tubular cell injury via STAT3 activation
Matsui, F., Rhee, A. C., Hile, K. L., Zhang, H., & Meldrum, K. K. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00620.2012 · Cited by 25
Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review
Grimminger, C., & Danenberg, P. V. (2010) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-010-1369-x · Cited by 25
Poincloux, R., Cougoule, C., Daubon, T., Maridonneau‐Parini, I., & Cabec, V. L. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21112 · Cited by 29
Yamasaki, K., Hanakawa, Y., Tokumaru, S., Shirakata, Y., Sayama, K., Hashimoto, K., Hanada, T., & Yoshimura, A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12100.x · Cited by 25
Neoplastic transformation by the gep oncogene, Gα12, involves signaling by STAT3
Kumar, R. N., Shore, S. K., & Dhanasekaran, N. (2005) · Oncogene · doi:10.1038/sj.onc.1209132 · Cited by 25
Feller, S. M., Tuchscherer, G., & Voss, J. H. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000037930 · Cited by 25
Kurt, H., Jorgensen, J. L., Amin, H. M., Patel, K. P., Wang, S. A., Lin, P., Kanagal‐Shamanna, R., Loghavi, S., Thakral, B., Khogeer, H. A., et al. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13038 · Cited by 24
Laka, K., Mapheto, K. B. F., & Mbita, Z. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.06.015 · Cited by 24
Mechanism of Pterostilbene-Induced Cell Death in HT-29 Colon Cancer Cells
Wawszczyk, J., Jesse, K., Smolik, S., & Kapral, M. (2022) · Molecules · doi:10.3390/molecules27020369 · Cited by 24
Sevimoğlu, T., & Arğa, K. Y. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0096 · Cited by 24
Badoux, X. C. A., Bueso-Ramos, C., Harris, D., Li, P., Liu, Z., Burger, J. A., O'Brien, S. M., Ferrajoli, A., Keating, M. J., & Estrov, Z. E. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.02.027 · Cited by 25
Lin, J., Buettner, R., Yuan, Y., Yip, R., Horne, D. A., Jove, R., & Vaidehi, N. (2009) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2009.08.013 · Cited by 24
Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3
Zhu, Q., & Jing, N. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9147-6 · Cited by 24
Knockdown of stat3 expression by RNAi inhibits in vitro growth of human ovarian cancer
Zhao, S., Zhao, F., Zheng, J., Gao, L., Zhao, X., & Cui, M. (2011) · Radiology and Oncology · doi:10.2478/v10019-011-0013-8 · Cited by 24
He, N., Feng, G., Yang, L., Xu, Y., Xie, X., Wang, H., Wang, Y., Ou, L., Pei, X., Liu, N., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0360-x · Cited by 24
Lou, C., Chen, Y., Zhang, J., Yang, B., & Zhao, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01071 · Cited by 24
RetractedSato, N., Kamada, N., Muromoto, R., Kawai, T., Sugiyama, K., Watanabe, T., Imoto, S., Sekine, Y., Ohbayashi, N., Ishida, M., et al. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.10.015 · Cited by 25
Novel roles of the CCR4–NOT complex
Chapat, C., & Corbo, L. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1254 · Cited by 24
Nifuroxazide ameliorates lipid and glucose metabolism in palmitate-induced HepG2 cells
Liu, J.-Y., Zhang, Y., Song, L., Zhang, L., Yang, F., Zhu, X.-R., Cheng, Z., Cao, X., & Yang, J.-K. (2019) · RSC Advances · doi:10.1039/c9ra06527j · Cited by 24
Li, S., Zhou, H., Xie, M., Zhang, Z., Gou, J., Yang, J., Tian, C., Ma, K., Wang, C., Lü, Y., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15803 · Cited by 23
Diffuse large B cell lymphoma: molecular targeted therapy
Roschewski, M. J., Dunleavy, K. M., & Wilson, W. H. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1198-3 · Cited by 23
Han, Z., Hong, Z., Gao, Q., Chen, C., Zhou, H., Ji, T., Hu, W., Yan, Y., Feng, J., Liao, S., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.101 · Cited by 24
Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA
Sun, J., Zheng, J., Ling, K. H., Zhao, K., Xie, Z., Li, B., Wang, T., Zhu, Z., Patel, A. N., Min, W., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-2 · Cited by 23
Cardiac hormones for the treatment of cancer
Vesely, D. L. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0054 · Cited by 23
Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3
Yang, J., Ren, Y., Lou, Z., Wan, X., Weng, G., & Cen, D. (2018) · Acta Pharmaceutica · doi:10.2478/acph-2018-0013 · Cited by 23
Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor
Yamamoto, T., Sato, N., Sekine, Y., Yumioka, T., Imoto, S., Junicho, A., Fuse, H., & Matsuda, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01026-x · Cited by 24
Han, Z., Hong, Z., Chen, C., Gao, Q., Luo, D., Fang, Y., Cao, Y., Zhu, T., Jiang, X., Ma, Q., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp249 · Cited by 24
Kopantzev, Y., Heller, M., Swaminathan, N., & Rudikoff, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205815 · Cited by 23
Signal transduction pathways of IL-1β-mediated iNOS in pulmonary vascular smooth muscle cells
Finder, J. D., Petrus, J. L., Hamilton, A. D., Villavicencio, R. T., Pitt, B. R., & Sebti, S. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.4.l816 · Cited by 23
Belletti, B., Drakas, R. A., Morrione, A., Tu, X., di Prisco, M., Yuan, T. L., Casaburi, I., & Baserga, R. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5542 · Cited by 23
3D culture reveals a signaling network
Muthuswamy, S. K. (2011) · Breast Cancer Research · doi:10.1186/bcr2800 · Cited by 26
Kong, R., Bharadwaj, U., Eckols, T. K., Kolosov, M. I., Wu, H., Cruz-Pavlovich, F. J. S., Shaw, A., Ifelayo, O. I., Zhao, H., Kasembeli, M. M., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105637 · Cited by 22
STAT3-dependent pathfinding and control of axonal branching and target selection
Conway, G. C. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.04.444 · Cited by 26
A novel cis-acting element in Her2 promoter regulated by Stat3 in mammary cancer cells
Lu, Q., Chen, L., Shi, M., Yu, M., Jin, B., Hu, M., Xia, Q., Zhang, X., Shen, B., & Guo, N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.153 · Cited by 23
Saalim, M., Resham, S., Manzoor, S., Ahmad, H., Jaleel, S., Ashraf, J., Imran, M., & Naseem, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-4294-1 · Cited by 22
Hußner, J., Ameling, S., Hammer, E., Herzog, S., Steil, L., Schwebe, M., Niessen, J., Schroeder, H. W. S., Kroemer, H. K., Ritter, C. A., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.075994 · Cited by 22
Goropevšek, A., Gorenjak, M., Gradišnik, S., Dai, K., Holc, I., Hojs, R., Krajnc, I., Pahor, A., & Avčin, T. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0040 · Cited by 22
MicroRNA-125b targeted STAT3 to inhibit laryngeal squamous cell carcinoma cell growth and motility
Feng, J., Fan, Y., Qukuerhan, A., Zhang, H., Yong, J., & Hu, B. (2017) · Oncology Letters · doi:10.3892/ol.2017.6155 · Cited by 22
Liu, A.-D., Xu, H., Gao, Y., Luo, D., Li, Z.-F., Voss, C., Li, S. S. ‐., & Cao, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0812-5 · Cited by 22
YAP promotes endothelial barrier repair by repressing STAT3/VEGF signaling
Fan, X., Shan, X., Jiang, S., Wang, S., Zhang, F., Tian, Q., Chen, D., Ma, J., Xue, F., Mao, S., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117884 · Cited by 23
Siavash, H., Nikitakis, N. G., & Sauk, J. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602055 · Cited by 22
Paul, B., Mishra, V., Chaudhury, B., Awasthi, A., Das, A. B., Saxena, U., Saxena, A., Chauhan, L. K. S., Kumar, P., & Raisuddin, S. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000155740 · Cited by 22
Coleman, D. R., Kaluarachchi, K., Ren, Z., Chen, X., & McMurray, J. S. (2007) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-007-9099-7 · Cited by 22
Montag, D. T., & Lotze, M. T. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.013 · Cited by 22
The role of stat5 in estrogen receptor-positive breast cancer
Yamashita, H., & Iwase, H. (2002) · Breast Cancer · doi:10.1007/bf02967610 · Cited by 22
Emerging immunotherapies for rheumatoid arthritis
Reynolds, G., Cooles, F. A. H., Isaacs, J. D., & Hilkens, C. M. U. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27910 · Cited by 21
Shimizu, S., Sunagawa, Y., Hajika, N., Natsumi, Y., Katanasaka, Y., Funamoto, M., Miyazaki, Y., Sari, N., Shimizu, K., Hasegawa, K., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65664 · Cited by 21
Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene
McAlexander, M. B., & Yu‐Lee, L. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00593-7 · Cited by 21
Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis
Liu, Q., Du, Y., Li, K., Zhang, W., Feng, X., Hao, J., Li, H., & Shu-xia, L. (2017) · Mediators of Inflammation · doi:10.1155/2017/3038514 · Cited by 21
Tian, F., Yang, X., Liu, Y., Yuan, X. F., Fan, T., Zhang, F., Zhao, J., Lü, J., Jiang, Y., Dong, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20838 · Cited by 21
Song, C., Fan, B., & Xiao, Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.039 · Cited by 21
Pak, S., Kim, W., Kim, Y., Song, C., & Ahn, H. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02993-1 · Cited by 21
Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
Aftabizadeh, M., Li, Y., Zhao, Q., Zhang, C., Ambaye, N. D., Song, J., Nagao, T., Lahtz, C., Fakih, M., Ann, D. K., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.136176 · Cited by 21
Guren, T. K., Ødegård, J., Abrahamsen, H., Thoresen, G. H., Šuša, M., Andersson, Y., Østby, E., & Christoffersen, T. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10282 · Cited by 23
Heck, E., Friedrich, U., Gack, M. U., Lengenfelder, D., Schmidt, M., Müller‐Fleckenstein, I., Fleckenstein, B., Ensser, A., & Biesinger, B. (2006) · Journal of Virology · doi:10.1128/jvi.01112-06 · Cited by 21
A CD25− Positive Population of Activated B1 Cells Expresses LIFR and Responds to LIF
Tumang, J. R., Holodick, N. E., Vizconde, T., Kaku, H., Francés, R., & Rothstein, T. L. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00006 · Cited by 21
A new family of transcription factors
Yamada, Y., Wang, H. Y., Fukuzawa, M., Barton, G. J., & Williams, J. G. (2008) · Development · doi:10.1242/dev.026377 · Cited by 21
Park, Y. J., Park, E. S., Kim, M. S., Kim, T. Y., Lee, H. S., Lee, S., Jang, I., Shong, M., Park, D. J., & Cho, B. Y. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00185-5 · Cited by 21
Chen, J., Jiang, L., Lan, K., & Chen, X. (2015) · Viruses · doi:10.3390/v7052268 · Cited by 20
Nguyen, V. T., Nardini, M., Ruggiu, A., Cancedda, R., Descalzi, F., & Mastrogiacomo, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145123 · Cited by 20
HOXA1, a breast cancer oncogene
Belpaire, M., Taminiau, A., Geerts, D., & Rezsöhazy, R. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188747 · Cited by 20
Lasfar, A., Cook, J. R., Cohen-Solal, K., Reuhl, K. R., Kotenko, S. V., Langer, J. A., & Laskin, D. L. (2014) · Immunology · doi:10.1111/imm.12273 · Cited by 23
Zhang, M., Zhu, W., & Li, Y. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.009 · Cited by 20
The role of insulin receptor substrate‐1 in transformation by v‐src
Sun, H., & Baserga, R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21352 · Cited by 20
Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling
Wang, Y., Ma, H., Zhao, C., Liu, T., Yan, D., Jou, D., Li, H., Zhang, C., Lü, J., Li, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16898 · Cited by 20
Al-Obeed, O. A., Vaali‐Mohammed, M., Eldehna, W. M., Al‐Khayal, K., Mahmood, A., Abdel‐Aziz, H. A., Zubaidi, A., Alafeefy, A. M., Abdulla, M., & Ahmad, R. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s148108 · Cited by 20
Matsuno, Y., Kiwamoto, T., Morishima, Y., Ishii, Y., Hizawa, N., & Hogaboam, C. M. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.09.001 · Cited by 20
Han, J.-H., Jang, K.-W., Park, M.-H., & Myung, C. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29964 · Cited by 20
Expression and prognostic significance of Stat5a and E‐cadherin in extramammary Paget’s disease
Liu, H., Urabe, K., Uchi, H., Takeuchi, S., Nakahara, T., Dainichi, T., Tu, Y., Furue, M., & Moroi, Y. (2006) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2006.00568.x · Cited by 20
The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer
Deng, H., Zhen, H., Fu, Z., Huang, X., Zhou, H., & Liú, L. (2011) · Oncology Letters · doi:10.3892/ol.2011.423 · Cited by 20
Effect of STAT3 inhibition on the metabolic switch in a highly STAT3-activated lymphoma cell line.
Akiyama, Y., Iizuka, A., Kume, A., Komiyama, M., Urakami, K., Ashizawa, T., Miyata, H., Omiya, M., Kusuhara, M., & Yamaguchi, K. (2015) · PubMed · Cited by 20
Bioactive polyprenylated benzophenone derivatives from the fruits extracts of Garcinia xanthochymus
Youn, U. J., Sripisut, T., Miklóssy, G., Turkson, J., Laphookhieo, S., & Chang, L. C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.06.073 · Cited by 20
Jiao, J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00286-9 · Cited by 20
Baśkiewicz‐Masiuk, M., Masiuk, M., & Machaliński, B. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00283.x · Cited by 20
Mikyšková, R., Sapeg, O., Psotka, M., Novotny, O., Hodný, Z., Balintova, S., Maliňák, D., Svobodová, J., Andrýs, R., Rysanek, D., et al. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.12968 · Cited by 19
TRPM7 contributes to pyroptosis and its involvement in status epilepticus
Tong, X., Tong, Y., Zheng, J., Shi, R., Liang, H., Li, M., Meng, Y., Shi, J., Zhao, D., Seehus, C. R., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03292-4 · Cited by 19
Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer
Haviland, R., Eschrich, S., Bloom, G., Ma, Y., Minton, S., Jove, R., & Cress, W. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024923 · Cited by 19
p23, a simple protein with complex activities
Felts, S. J., & Toft, D. O. (2003) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2003)008 · Cited by 116
Theoretical and gas‐phase studies of specific cationized purine base quartet
Mezzache, S., Alvès, S., Paumard, J., Pèpe, C., & Tabet, J. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2934 · Cited by 19
Signal transducer and activator of transcription 3 regulation by novel binding partners
Matsuda, T. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.324 · Cited by 19
Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma
Soleimani, A., Garg, S. M., de Paiva, I. M., Vakili, M. R., Alshareef, A., Huang, Y.-H., Molavi, O., Lai, R. L., & Lavasanifar, A. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0369-4 · Cited by 20
Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors
Guo, J., Yu, W., Cai, G., Zhang, W., Li, S., Zhu, J., Song, D., & Kong, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.053 · Cited by 19
Li, Y., Ren, Q., Zhu, L., Li, Y., Li, J., Zhang, Y., Zheng, G., Han, T., Sun, S., & Feng, F. (2018) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0201-x · Cited by 19
Dichotomy of cellular inhibition by small-molecule inhibitors revealed by single-cell analysis
VOGEL, R. M., Erez, A., & Altan-Bonnet, G. Y. (2016) · Nature Communications · doi:10.1038/ncomms12428 · Cited by 19
Chang, L. C., Sang-ngern, M., Pezzuto, J. M., & Ma, C. (2016) · PubMed Central · Cited by 19
Connexin 32 as an Anti-invasive and Anti-metastatic Gene in Renal Cell Carcinoma
Yano, T., Fujimoto, E., Hagiwara, H., Sato, H., Yamasaki, H., Negishi, E., & Ueno, K. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1991 · Cited by 19
Yin, S., Wu, H., Lv, J., Wu, X., Zhang, Y., Du, J., & Zhang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086330 · Cited by 19
Gao, C., Mi, Z., Guo, H., & Kuo, P. C. (2007) · Neoplasia · doi:10.1593/neo.07463 · Cited by 19
Sud, N., Kumar, S., Wedgwood, S., & Black, S. M. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90534.2008 · Cited by 19
Li, H., Cai, M., Cao, F., Yu, D., Yang, J., Yu, W.-K., Chu, C., Guan, X., Qin, J., & Dong, J. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116941 · Cited by 18
Metadata
- Authors
- Bromberg, J., & Darnell, J. E.
- Affiliations
- Rockefeller University (US)
- ORCID
- Bromberg, Jacqueline
- Venue
- Oncogene
- Published
- 2000-05-25
- Volume
- 19
- Issue
- 21
- Pages
- 2468-2473
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977681992
- Cited by
- 1,201
- References
- 66
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 21 · 2023: 24 · 2022: 37 · 2021: 40 · 2020: 46 · 2019: 41 · 2018: 42 · 2017: 51 · 2016: 46 · 2015: 49 · 2014: 59 · 2013: 67 · 2012: 56
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT proteins, transcriptional regulation, cytokine signaling, JAK kinases, tyrosine phosphorylation, STAT1, STAT3, STAT5, cell cycle progression, apoptosis, tumor suppressor, cell transformation, carcinogenesis, transcriptional coactivator
- MeSH terms
- Animals, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Gene Expression Regulation, Humans, Milk Proteins, Neoplasms, Structure-Activity Relationship, Transcription, Genetic, Trans-Activators, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
